5 results

• FDA Effort to Recall Tavneos Challenged by Drug Maker

  August 3, 2026

  Irvin Jackson

  Amgen is asking the FDA to reconsider pulling the drug Tavneos from the market, saying their own data shows the drug works as intended.

• Tavneos Lawsuits Over Liver Injury Side Effects May Follow Recall Proposals

  July 23, 2026

  Irvin Jackson

  Amgen may face an increasing threat of Tavneos lawsuits as more countries begin investigating whether the original creators falsified data to get the drug approved.

• Tavneos Recall Pressure Mounts, As EU Joins FDA Seeking Market Removal

  July 1, 2026

  Irvin Jackson

  The EU weighs a Tavneos recall following the release of data suggesting the autoimmune treatment's clinical trial results were manipulated to make Tavneos look safer and more effective than it actually is.

• Tavneos Liver Injury Risks, Faked Data Lead FDA To Seek Market Removal

  April 29, 2026

  Irvin Jackson

  Amgen has received a letter from the FDA indicating the agency plans to remove Tavneos from the market after discovering falsified data in the original clinical trial.

• Tavneos Side Effects Linked to Severe Liver Injuries, FDA Warns

  April 1, 2026

  Michael Adams

  Federal regulators warn Tavneos may cause serious and potentially fatal liver injuries, with postmarketing data identifying 76 adverse cases, including 54 hospitalizations and eight deaths.